Gossamer Bio Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.42

-0.53 (-5.33%)

As of Nov 7, 2:02 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 62%

Hold 4 31%

Sell 1 8%

Price Target

Analyst Price Target +191.0% upside

Low Target $18.46

Average Target $27.41

High Target $44.08

Current Price $9.42

Current
$9.42

Target
$27.41

$18.46 $27.41 avg $44.08

Scenario Analysis

Bear Case

$18.46

96.0%

Low target

Base Case

$27.41

+191.0%

Avg target

Bull Case

$44.08

+367.9%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$309.60

-97.0% from high

52-Week Low

$8.29

+13.6% from low

Target vs 52W High

$27.41

-91.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%